Centennial Surgical Suture reports net loss for FY26
Centennial Surgical Suture Ltd reported a widened net loss of ₹220.46 lakh for FY26, compared to ₹146.37 lakh in the previous year, with total income from operations rising marginally to ₹5400.83 lakh. For Q4FY26, the net loss stood at ₹231.35 lakh on an income of ₹1265.08 lakh. The Board approved the audited results on May 30, 2026.
*this image is generated using AI for illustrative purposes only.
Centennial Surgical Suture Ltd reported a net loss of ₹220.46 lakh for the financial year ended March 31, 2026, widening from the net loss of ₹146.37 lakh recorded in the previous year. Total income from operations for the fiscal year stood at ₹5400.83 lakh, slightly higher than the ₹5363.63 lakh reported in the prior year. The company's financial performance was impacted by operational challenges, resulting in a basic earnings per share (EPS) of ₹(6.04) for the year.
For the quarter ended March 31, 2026, the company posted a net loss of ₹231.35 lakh, a significant decline from the net loss of ₹118.35 lakh in the corresponding quarter of the previous year. Total income from operations for the quarter decreased to ₹1265.08 lakh from ₹1335.76 lakh in the same period last year. The basic EPS for the quarter stood at ₹(6.34), reflecting the continued pressure on profitability.
The Board of Directors reviewed and approved the standalone audited financial results at a meeting held on May 30, 2026. The results were also reviewed by the Audit Committee prior to the Board's approval. The company disclosed that the financial results are an extract of the detailed format filed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Equity share capital remained unchanged at ₹364.83 lakh for the quarter and year ended March 31, 2026. Reserves, excluding revaluation reserves, were reported at ₹2533.06 lakh for the current year, down from ₹2679.39 lakh in the previous year. The total comprehensive income for the year was ₹(220.46) lakh, mirroring the net loss for the period as there were no other comprehensive income items reported.
Standalone Financial Results
| Particulars | Quarter ended Mar 31, 2026 (Audited) | Year ended Mar 31, 2026 (Audited) |
|---|---|---|
| Total Income from Operations (net) | 1265.08 | 5400.83 |
| Net Profit / (Loss) for the period before tax | (222.89) | (208.34) |
| Net Profit / (Loss) for the period after tax | (231.35) | (220.46) |
| Total Comprehensive Income for the period | (231.35) | (220.46) |
| Equity Share Capital | 364.83 | 364.83 |
| Basic EPS (₹) | (6.34) | (6.04) |
The detailed financial results are available on the company's website and the BSE Limited website. The filing confirms compliance with Regulation 47 of the SEBI (LODR) Regulations, 2015, regarding the publication of audited financial results in newspapers.
Historical Stock Returns for Centenial Surgical Suture
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.27% | -8.44% | -20.83% | -17.75% | -42.11% | +74.79% |
What specific operational challenges are driving the widening losses, and what steps is management taking to address them?
With reserves declining, does the company have sufficient liquidity to sustain operations while it attempts to return to profitability?
Is the decline in quarterly operational income expected to persist into the next fiscal year, or are there seasonal factors at play?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
